FDA Inspection 1083313 — Diana-Hortensia Barbonta, MD
The FDA completed an inspection of Diana-Hortensia Barbonta, MD on Mar 1, 2019 in Alba Iulia. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 1, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Alba Iulia (Romania)
Additional Details
Clinical Investigator (CI)